XS0601 reduces the incidence of restenosis: a prospective study of 335 patients undergoing percutaneous coronary intervention in China-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

XS0601 reduces the incidence of restenosis: a prospective study of 335 patients undergoing percutaneous coronary intervention in China

Published:2006-01 Issue:1 Volume:119 Page:6-13
ISSN:0366-6999
Container-title:Chinese Medical Journal
language:en
Short-container-title:Chinese Medical Journal

Author:

CHEN Ke-ji,SHI Da-zhuo,XU Hao,LÜ Shu-zheng,LI Tian-chang,KE Yuan-nan,ZHANG Min-zhou,LU Xiao-yan,SUN Rui-yuan,YOU Shi-jie

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference29 articles.

1. A prospective, randomized trial comparing combination half-dose tissue-type plasminogen activator and streptokinase with full-dose tissue-type plasminogen activator. Kentucky Acute Myocardial Infarction Trial (KAMIT) Group.

2. Long-term Effects of Angiopeptin Treatment in Coronary Angioplasty

3. Effect of nifedipine on recurrent stenosis after percutaneous transluminal coronary angioplasty

4. Effects of diltiazem on complications and restenosis after coronary angioplasty

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy of traditional Chinese herbal medicine across multiple cardiovascular diseases: an umbrella review of systematic reviews of randomized controlled trials;Journal of Cardiovascular Pharmacology;2024-01-09

2. Comparative efficacy of different Chinese patent medicines in preventing restenosis after percutaneous coronary intervention: a systematic review and Bayesian network meta-analysis of randomized clinical trials;Frontiers in Pharmacology;2024-01-05

3. Clinical evidence and mechanisms of traditional Chinese medicine in major diseases;Science of Traditional Chinese Medicine;2023-09

4. Theory and scientificity of traditional Chinese medicine;Science of Traditional Chinese Medicine;2023-09

5. Protective effects of paeoniflorin on cardiovascular diseases: A pharmacological and mechanistic overview;Frontiers in Pharmacology;2023-05-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3